Dr. Danielle N. Larson
Neurology (Neurology Physician)
240 E Huron St, Mcgaw Medical Center Of Northwestern Univsersity
Chicago, IL 60611
Who else practices at this address →
Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Tufts University School of Medicine (2014)
- Years since graduation
- 12
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 248
Licensed in Illinois since 2018, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Medical school: Tufts University School of Medicine
- 2014Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
IL license 036.145860 (first issued 2018; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Northwestern Medicine Central Dupage Hospital Winfield, IL
- Northwestern Memorial Hospital Chicago, IL
- Northwestern Lake Forest Hospital Lake Forest, IL
Medical groups
- Northwestern Medical Faculty Foundation (4,503 clinicians)
- Select Rehabilitation, LLC (2,046 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 248
- Services billed
- 6,349
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 5,200 | 13 |
| Established patient office or other outpatient visit, 40-54 minutes | 169 | 109 |
| Established patient office or other outpatient visit, 30-39 minutes | 36 | 31 |
| New patient office or other outpatient visit, 60-74 minutes | 34 | 34 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 17 | 17 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Chicago, IL | 349 |
| Amantadine (amantadine hcl) Other prescribers in Chicago, IL | 81 |
| Primidone Other prescribers in Chicago, IL | 69 |
| Donepezil Hcl Other prescribers in Chicago, IL | 61 |
| Carbidopa-Levodopa Er (carbidopa/levodopa) Other prescribers in Chicago, IL | 59 |
| Propranolol Hcl Other prescribers in Chicago, IL | 55 |
| Rytary (carbidopa/levodopa) Other prescribers in Chicago, IL | 54 |
| Propranolol Hcl Er (propranolol hcl) Other prescribers in Chicago, IL | 49 |
| Escitalopram Oxalate Other prescribers in Chicago, IL | 42 |
| Pregabalin Other prescribers in Chicago, IL | 36 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 5 payments worth $742 in total to this clinician.
| Vertex Pharmaceuticals Incorporated | $589 |
|---|---|
| Neurocrine Biosciences, Inc. | $153 |
| Consulting Fee | $589 |
|---|---|
| Food and Beverage | $153 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Vertex Pharmaceuticals Incorporated Mar 24, 2025 | Consulting Fee | $303 |
| Vertex Pharmaceuticals Incorporated Nov 14, 2025 | Consulting Fee | $286 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $115,873 in research payments for these studies, mostly to the institutions running them.
- A Phase 2b efficacy safety trial of Prasinezumab in patients with early Parkinson s Disease
Genentech, Inc. - Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)
Eli Lilly and Company · Active, not recruiting · NCT04127578
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.